SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004584
Filing Date
2019-05-09
Accepted
2019-05-09 10:09:52
Documents
53
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q albo-20190331x10q.htm 10-Q 1084612
2 EX-10.1 albo-20190331ex10137690f.htm EX-10.1 157657
3 EX-10.2 albo-20190331ex10275a295.htm EX-10.2 28387
4 EX-31.1 albo-20190331ex3111afa14.htm EX-31.1 11737
5 EX-31.2 albo-20190331ex3129abd5e.htm EX-31.2 11638
6 EX-32.1 albo-20190331ex321a08589.htm EX-32.1 12227
7 GRAPHIC albo20190331ex10137690f001.jpg GRAPHIC 2820
8 GRAPHIC albo20190331ex10137690f002.jpg GRAPHIC 5349
  Complete submission text file 0001558370-19-004584.txt   3748395

Data Files

Seq Description Document Type Size
9 EX-101.INS albo-20190331.xml EX-101.INS 519235
10 EX-101.SCH albo-20190331.xsd EX-101.SCH 30663
11 EX-101.CAL albo-20190331_cal.xml EX-101.CAL 31119
12 EX-101.DEF albo-20190331_def.xml EX-101.DEF 93263
13 EX-101.LAB albo-20190331_lab.xml EX-101.LAB 318229
14 EX-101.PRE albo-20190331_pre.xml EX-101.PRE 219513
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33451 | Film No.: 19809180
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1